Fluorine 18-tagged fluorodeoxyglucose positron emission tomographic scanning to predict lymph node metastasis, invasiveness, or both, in clinical T1 NO MO lung adenocarcinoma

被引:33
|
作者
Nomori, H
Watanabe, K
Ohtsuka, T
Naruke, T
Suemasu, K
Kobayashi, T
Uno, K
机构
[1] Saiseikai Cent Hosp, Dept Thorac Surg, Minato Ku, Tokyo 1080073, Japan
[2] Natl Canc Ctr, Endoscopy Div, Tokyo, Japan
[3] Nishidai Clin, Tokyo, Japan
来源
关键词
D O I
10.1016/j.jtcvs.2004.03.020
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: We sought to predict lymph node metastasis and tumor invasiveness in clinical T1 N0 M0 lung adenocarcinomas, and we measured fluorodeoxyglucose uptake on positron emission tomography. Methods: Fluorodeoxyglucose positron emission tomography was performed on 44 patients with adenocarcinomas of 1 to 3 cm in size clinically staged as T1 N0 M0 before major lung resection with lymph node dissection. Fluorodeoxyglucose uptake was evaluated by using the contrast ratio between the tumor and contralateral healthy lung tissue. Lymphatic and vascular invasion within tumors, pleural involvement, and grade of histologic differentiation were examined. Results: The pathologic tumor stage was T1 N0 M0 in 36 patients, and a more advanced stage was found in 8 patients. Although all 22 adenocarcinomas with a contrast ratio of less than 0.5 in fluorodeoxyglucose uptake were pathologic T1 N0 M0 tumors, 8 (36%) of 22 with a contrast ratio of 0.5 or greater were of a more advanced stage than T1 N0 M0, with the difference being significant (P = .002). Adenocarcinomas with a contrast ratio of less than 0.5 showed less lymphatic and vascular invasion and less pleural involvement than those with a contrast ratio of 0.5 or greater (P = .006, P = .004, and P = .02, respectively). The grade of histologic differentiation was well differentiated in 19 of 22 adenocarcinomas with a contrast ratio of less than 0.5 (86%), which was a greater frequency than the 4 (18%) of 22 adenocarcinomas with a contrast ratio of 0.5 or greater (P < .001). Conclusion: Clinical T1 N0 M0 lung adenocarcinomas with a contrast ratio of less than 0.5 usually did not have lymph node metastasis, had less tumor involvement of vessels or pleura, and were more frequently well differentiated than those with a contrast ratio of 0.5 or greater. Limited lung resection could be indicated, lymph node dissection or mediastinoscopy could be reduced, or both in this type of adenocarcinoma.
引用
收藏
页码:396 / 401
页数:6
相关论文
共 44 条
  • [21] Comparison between solid component size on thin-section CT and pathologic lymph node metastasis and local invasion in T1 lung adenocarcinoma
    Hayashi, Hideyuki
    Ashizawa, Kazuto
    Ogihara, Yukihiro
    Nishida, Akifumi
    Matsumoto, Keitaro
    Yamasaki, Naoya
    Nagayasu, Takeshi
    Fukuda, Minoru
    Honda, Sumihisa
    Uetani, Masataka
    JAPANESE JOURNAL OF RADIOLOGY, 2017, 35 (03) : 109 - 115
  • [22] Comparison between solid component size on thin-section CT and pathologic lymph node metastasis and local invasion in T1 lung adenocarcinoma
    Hideyuki Hayashi
    Kazuto Ashizawa
    Yukihiro Ogihara
    Akifumi Nishida
    Keitaro Matsumoto
    Naoya Yamasaki
    Takeshi Nagayasu
    Minoru Fukuda
    Sumihisa Honda
    Masataka Uetani
    Japanese Journal of Radiology, 2017, 35 : 109 - 115
  • [23] Re-evaluating the need for mediastinal lymph node dissection and exploring lncRNAs as biomarkers of N2 metastasis in T1 lung adenocarcinoma
    Hao, Xuefeng
    Li, Weiying
    Li, Wei
    Gu, Meng
    Wang, Ziyu
    Nakahashi, Kenta
    Antonoff, Mara B.
    Adachi, Hiroyuki
    Zhou, Shijie
    Xu, Shaofa
    TRANSLATIONAL LUNG CANCER RESEARCH, 2022, 11 (06) : 1079 - +
  • [24] Correlation between lymph node metastasis and the expression of VEGF-C, VEGF-D and VEGFR-3 in t1 lung adenocarcinoma
    Maekawa, Shinichi
    Iwasaki, Akinori
    Shirakusa, Takayuki
    Enatsu, Sotaro
    Kawakami, Takehito
    Kuroki, Motomu
    Kuroki, Masahide
    ANTICANCER RESEARCH, 2007, 27 (6A) : 3735 - 3741
  • [25] Predicting lymph node metastasis of clinical T1 non-small cell lung cancer: a brief review of possible methodologies and controversies
    Zhang, Li
    Zhang, Feiyue
    Li, Gaofeng
    Xiang, Xudong
    Liang, Haifeng
    Zhang, Yan
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [26] Combination of Fluorine-18 Fluorodeoxyglucose Positron-Emission Tomography/Computed Tomography (18F-FDG PET/CT) and Tumor Markers to Diagnose Lymph Node Metastasis in Non-Small Cell Lung Cancer (NSCLC): A Retrospective and Prospective Study
    Zhai, Xiaoli
    Guo, Yuehong
    Qian, Xiaojun
    MEDICAL SCIENCE MONITOR, 2020, 26
  • [27] Fluorine-18 fluorodeoxyglucose positron emission tomographic maximal standardized uptake value predicts survival independent of clinical but not pathologic TNM staging of resected non-small cell lung cancer
    Downey, Robert J.
    Akhurst, Timothy
    Gonen, Mithat
    Park, Bernard
    Rusch, Valerie
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2007, 133 (06): : 1419 - 1424
  • [28] Fluorine-18 fluorodeoxyglucose positron emission tomographic maximal standardized uptake value predicts survival independent of clinical but not pathologic TNM staging of resected non-small cell lung cancer - Discussion
    Reed, Carolyn R.
    Downey
    Cerfolio, Robert J.
    Miller, Daniel L.
    Yim, Anthony P.
    Detterbeck, Frank C.
    Howington, John
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2007, 133 (06): : 1425 - 1427
  • [29] Deep Learning Analysis Using 18F-FDG PET/CT to Predict Occult Lymph Node Metastasis in Patients With Clinical N0 Lung Adenocarcinoma
    Ouyang, Ming-li
    Zheng, Rui-xuan
    Wang, Yi-ran
    Zuo, Zi-yi
    Gu, Liu-dan
    Tian, Yu-qian
    Wei, Yu-guo
    Huang, Xiao-ying
    Tang, Kun
    Wang, Liang-xing
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [30] Deep-learning features based on F18 fluorodeoxyglucose positron emission tomography/computed tomography (18F-FDG 18 F-FDG PET/CT) to predict preoperative colorectal cancer lymph node metastasis
    Wang, H.
    Zhang, J.
    Li, Y.
    Wang, D.
    Zhang, T.
    Yang, F.
    Zhang, Y.
    Yang, L.
    Li, P.
    CLINICAL RADIOLOGY, 2024, 79 (09) : e1152 - e1158